Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Glooko Inks Partnership Deal With Companion Medical To Integrate Insulin Pen Data

Executive Summary

Glooko entered a partnership to integrate Companion Medical's InPen insulin data into Glooko's diabetes management systems.

You may also be interested in...



ADA 2019: Real-World Study Shows Abbott's FreeStyle Libre CGM Reduced HbA1c Levels In Type 2 Diabetics

At this year's annual American Diabetes Association (ADA) conference, Abbott presented real-world data from its FreeStyle Libre CGM suggesting it reduces HbA1c in type 2 diabetics. Look for more ADA coverage this week.

Glooko And T1D Exchange Enter Partnership To Leverage Device Data From Type 1 Diabetics

T1D Exchange, a nonprofit research group, will use Glooko’s diabetes data management platform to leverage diabetes device data from thousands of type 1 diabetics and link it with patients’ health records data at participating medical centers. Thanks to the agreement, researchers will gain access to data that can be used to improve patient care and outcomes.

NANS 2020: SPR Therapeutics' Nerve Stimulation System Provides 12-Month Pain Relief After 60-Day Treatment

SPR Therapeutics said its SPRINT neurostimulation technology achieved a 63% reduction in average pain intensity in patients with chronic low back pain.

Topics

Related Companies

UsernamePublicRestriction

Register

MT125209

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel